← Back to Search

ReCharge for Type 1 Diabetes (ChargeUp Trial)

N/A
Waitlist Available
Led By Anna Kahkoska, MD, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults 30 years and older
Type 1 diabetes OR latent autoimmune diabetes in adults (LADA) clinically managed as type 1 diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

ChargeUp Trial Summary

This study is designed to test the feasibility and acceptability of behavioral approaches to reduce diabetes distress ("the expected burdens, concerns, fears, and threats that arise from the challenges of living with diabetes") in adults with type 1 diabetes. This is a pilot study, which will enroll a small group of participants to enroll and give feedback on their experience. At the study baseline, participants will be randomized to take part in one of two virtual, group-based interventions (the "Primary" intervention) utilizing either an emotions-focused or a problem-solving approach to reduce diabetes distress. After the intervention, participants will attend focus groups and fill out anonymous qualitative surveys to give feedback on their experience. Results of the pilot will inform and improve an upcoming research study of the same design.

Eligible Conditions
  • Type 1 Diabetes
  • Emotional Distress
  • Diabetes

ChargeUp Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check β€œYes” for the criteria below

ChargeUp Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Total Diabetes Distress (T1-DDS Total Score)
Secondary outcome measures
Change in Core Diabetes Distress (T1-DDAS Core Score)
Change in Diabetes Quality of Life
Change in Diabetes Specific Self-Compassion
+9 more
Other outcome measures
Intervention Satisfaction
Long-term Change in Core Diabetes Distress (T1-DDAS Core Score)
Long-term Change in Glycemic Variability
+7 more

ChargeUp Trial Design

2Treatment groups
Experimental Treatment
Group I: TakeChargeExperimental Treatment1 Intervention
Participants randomized to TakeCharge will participate in a problem-solving focused intervention facilitated by a diabetes care professional.
Group II: ReChargeExperimental Treatment1 Intervention
Participants randomized to ReCharge will participate in an emotions-focused intervention facilitated by a mental health professional.

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,513 Previous Clinical Trials
4,194,373 Total Patients Enrolled
American Diabetes AssociationOTHER
141 Previous Clinical Trials
99,806 Total Patients Enrolled
Anna Kahkoska, MD, PhDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
1 Previous Clinical Trials
200 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Aug 2024